A qualitative study of biosimilar manufacturer and regulator perceptions on intellectual property and abbreviated approval pathways
Publication date
2020-11-01
Authors
Druedahl, Louise C.
Almarsdóttir, Anna Birna
Kälvemark Sporrong, Sofia
De Bruin, Marieke
Hoogland, Hans
Minssen, Timo
van de Weert, Marco
Kesselheim, Aaron S.
Sarpatwari, Ameet
Editors
Advisors
Supervisors
Document Type
Article
Metadata
Show full item recordCollections
License
taverne
Abstract
Keywords
Taverne, Biotechnology, Bioengineering, Applied Microbiology and Biotechnology, Molecular Medicine, Biomedical Engineering
Citation
Druedahl, L C, Almarsdóttir, A B, Kälvemark Sporrong, S, De Bruin, M L, Hoogland, H, Minssen, T, van de Weert, M, Kesselheim, A S & Sarpatwari, A 2020, 'A qualitative study of biosimilar manufacturer and regulator perceptions on intellectual property and abbreviated approval pathways', Nature Biotechnology, vol. 38, no. 11, pp. 1253-1256. https://doi.org/10.1038/s41587-020-0717-7